Dow Down1.17% Nasdaq Down1.19%

More On GEVA

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
238.60 0.00(0.00%) Jun 22
HeadlinesGet Headlines for:

No headlines available for GEVA prior to December 31, 2012.